# Neonatal White Matter Injury Trial (WRAP)

> **NCT07688746** · PHASE1 · RECRUITING · sponsor: **Bridget LaMonica Ostrem, M.D., Ph.D.** · enrollment: 24 (estimated)

## Conditions studied

- White Matter Injury
- Brain Injury, Fetus and Neonate
- Neonatal Brain Injury
- Periventricular Leukomalacia
- Periventricular White Matter Abnormalities

## Interventions

- **DRUG:** Clemastine fumarate

## Key facts

- **NCT ID:** NCT07688746
- **Lead sponsor:** Bridget LaMonica Ostrem, M.D., Ph.D.
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-07-26
- **Primary completion:** 2028-04-01
- **Final completion:** 2031-07-01
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2026-07-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07688746

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07688746, "Neonatal White Matter Injury Trial (WRAP)". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07688746. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*